{
  "id": "nclex_ngn_trend_mission_500_109",
  "questionType": "trend",
  "caseId": "cardiogenic_shock_500",
  "title": "Cardiogenic Shock with Arrhythmia",
  "body": "A 68-year-old client with a history of hypertension and hyperlipidemia was admitted to the cardiac intensive care unit (CICU) 4 hours ago following an emergent percutaneous coronary intervention (PCI) for a large anterior wall ST-elevation myocardial infarction (STEMI). The client developed cardiogenic shock post-procedure. The client reports inconsistent access to primary care due to transportation issues, leading to poorly managed chronic conditions. The nurse is preparing to implement a new provider's order.",
  "tabs": [
    {
      "id": "nurses_notes",
      "title": "Nurses' Notes",
      "type": "text",
      "content": [
        {
          "time": "0800",
          "note": "Client transferred to CICU post-PCI. Alert and oriented x3, responds to questions. Skin is cool and pale. Bilateral breath sounds with fine crackles in the bases. S1S2 audible, S3 gallop noted. Peripheral pulses +1 radial and dorsalis pedis. Urine output via indwelling catheter is 15 mL/hr. Norepinephrine and Dobutamine infusions initiated and titrated per protocol to maintain MAP >65 mmHg."
        },
        {
          "time": "1000",
          "note": "Client appears more anxious. Complains of mild shortness of breath. Crackles now audible in lower half of lung fields bilaterally. Skin remains cool. MAP has been maintained between 68-72 mmHg. Urine output 20 mL over the past hour. Provider notified of respiratory status change."
        },
        {
          "time": "1200",
          "note": "Client is restless and agitated. BP remains low despite increased vasopressor support. Heart rate is persistently tachycardic. Monitor shows frequent multifocal premature ventricular contractions (PVCs). One brief, 6-second run of a wide-complex tachycardia was observed, which resolved spontaneously. SpO2 is difficult to maintain above 92%. Provider is aware of rhythm changes."
        }
      ]
    },
    {
      "id": "vital_signs",
      "title": "Vital Signs",
      "type": "table",
      "data": {
        "headers": [
          "Time",
          "HR (bpm)",
          "BP (mmHg)",
          "MAP (mmHg)",
          "SpO2 (%)",
          "RR (breaths/min)",
          "CVP (mmHg)"
        ],
        "rows": [
          [
            "0800",
            "105",
            "82/56",
            "65",
            "94% on 4L NC",
            "22",
            "16"
          ],
          [
            "1000",
            "110",
            "88/62",
            "71",
            "93% on 4L NC",
            "24",
            "18"
          ],
          [
            "1200",
            "122",
            "84/60",
            "68",
            "92% on 6L NC",
            "26",
            "19"
          ]
        ]
      }
    },
    {
      "id": "diagnostic_results",
      "title": "Diagnostic Results",
      "type": "text",
      "content": [
        {
          "type": "Laboratory Results",
          "time": "0800",
          "results": [
            "Troponin-I: 25.2 ng/mL (Reference: <0.04 ng/mL)",
            "Lactate: 4.8 mmol/L (Reference: 0.5-2.2 mmol/L)",
            "Potassium (K+): 3.6 mEq/L (Reference: 3.5-5.0 mEq/L)",
            "BUN: 34 mg/dL (Reference: 7-20 mg/dL)",
            "Creatinine: 1.8 mg/dL (Reference: 0.6-1.2 mg/dL)"
          ]
        },
        {
          "type": "ECG Interpretation",
          "time": "1215",
          "results": [
            "Rhythm: Sinus Tachycardia at 122 bpm.",
            "Findings: Frequent multifocal premature ventricular contractions (PVCs). A 6-beat run of non-sustained ventricular tachycardia (NSVT) is noted. Q-waves in anterior leads consistent with recent infarct."
          ]
        }
      ]
    },
    {
      "id": "mar",
      "title": "MAR",
      "type": "text",
      "content": [
        {
          "type": "Continuous Infusions",
          "medications": [
            "Norepinephrine 8 mg in 250 mL D5W, infusing at 10 mcg/min.",
            "Dobutamine 500 mg in 250 mL D5W, infusing at 5 mcg/kg/min."
          ]
        },
        {
          "type": "PRN Medications",
          "medications": [
            "Amiodarone 150 mg IV push over 10 minutes, for symptomatic ventricular arrhythmias."
          ]
        },
        {
          "type": "New Orders",
          "time": "1230",
          "medications": [
            "Increase Dobutamine infusion to 7.5 mcg/kg/min."
          ]
        }
      ]
    }
  ],
  "stem": "The nurse reviews the client's electronic health record. Which of the following actions should the nurse take in response to the new order at 1230? Select all that apply.",
  "scoring": {
    "type": "multiSelect",
    "correct": [
      "option_1",
      "option_3",
      "option_4"
    ]
  },
  "options": [
    {
      "id": "option_1",
      "label": "Withhold the dobutamine infusion increase."
    },
    {
      "id": "option_2",
      "label": "Increase the norepinephrine infusion to 15 mcg/min."
    },
    {
      "id": "option_5",
      "label": "Administer a 250 mL bolus of 0.9% sodium chloride."
    },
    {
      "id": "option_4",
      "label": "Prepare to administer the PRN amiodarone."
    },
    {
      "id": "option_3",
      "label": "Contact the provider to question the dobutamine order and report the latest ECG findings."
    },
    {
      "id": "option_6",
      "label": "Request an order for an arterial blood gas (ABG)."
    }
  ],
  "answerBreakdown": {
    "option_1": {
      "correct": true,
      "rationale": "**Correct:** Withholding the dobutamine is paramount. The client exhibits signs of worsening cardiac instability: increasing heart rate (105 to 122 bpm), frequent PVCs, and a brief run of NSVT. Dobutamine, a beta-1 adrenergic agonist, increases myocardial contractility and heart rate, thereby increasing myocardial oxygen demand. In cardiogenic shock post-MI, the heart is already struggling to meet its own oxygen needs. Increasing dobutamine can exacerbate ischemia and worsen arrhythmias. \n\n**Pathophysiology:** Cardiogenic shock occurs when the heart's pumping ability is severely compromised, leading to inadequate tissue perfusion. In this case, the large anterior wall STEMI has damaged a significant portion of the left ventricle. Dobutamine's inotropic effects, while potentially beneficial for increasing cardiac output, can be detrimental in the presence of ischemia and electrical instability. The increased oxygen demand can lead to further myocardial damage and life-threatening arrhythmias.\n\n**Clinical Pearl:** Always assess for signs of worsening ischemia (chest pain, ST-segment changes, arrhythmias) when administering inotropic agents like dobutamine, especially in post-MI patients. Arrhythmias are a major cause of mortality in cardiogenic shock.",
      "highlight": []
    },
    "option_2": {
      "correct": false,
      "rationale": "**Incorrect:** While the client's MAP is borderline (68 mmHg), increasing norepinephrine is not the immediate priority. Norepinephrine is a potent vasoconstrictor that increases afterload. In cardiogenic shock, an already compromised heart is struggling to pump against increased resistance. While norepinephrine can improve blood pressure, it does not address the underlying arrhythmia and can further strain the heart. \n\n**Pathophysiology:** Norepinephrine primarily stimulates alpha-adrenergic receptors, causing vasoconstriction. This increases systemic vascular resistance (SVR), which the left ventricle must overcome to eject blood. In cardiogenic shock, the left ventricle is already failing, and increasing afterload can further reduce cardiac output.\n\n**Clinical Pearl:** In cardiogenic shock, prioritize optimizing cardiac output and addressing arrhythmias before aggressively increasing vasopressors. Excessive vasoconstriction can worsen tissue perfusion and increase myocardial workload.",
      "highlight": []
    },
    "option_3": {
      "correct": true,
      "rationale": "**Correct:** Contacting the provider is essential. The nurse must communicate the client's deteriorating condition, specifically the new ECG findings (NSVT) and the client's restlessness, which could indicate worsening hypoperfusion or anxiety related to the arrhythmia. Questioning the dobutamine order is crucial, as increasing it could be detrimental. The nurse should use SBAR to provide a concise and organized report.\n\n**SBAR Communication (1230):**\n*   **Situation:** \"This is [Nurse's Name] calling from the CICU regarding [Client's Name] in cardiogenic shock post-STEMI. I'm concerned about a new order to increase the dobutamine infusion.\"\n*   **Background:** \"The client had a large anterior wall STEMI and underwent PCI 4 hours ago. They are currently on norepinephrine and dobutamine infusions. Their history includes hypertension and hyperlipidemia.\"\n*   **Assessment:** \"The client is increasingly restless and agitated. Their heart rate is 122 bpm, and the ECG shows frequent PVCs and a 6-second run of NSVT. SpO2 is 92% on 6L NC. CVP is 19 mmHg. Urine output has been low. Troponin is elevated at 25.2 ng/mL. Lactate is 4.8 mmol/L.\"\n*   **Recommendation:** \"Given the new onset of ventricular tachycardia and the client's overall condition, I'm concerned that increasing the dobutamine infusion could worsen the arrhythmia and myocardial ischemia. I recommend holding the increase and considering alternative strategies to improve cardiac output and manage the arrhythmia, such as amiodarone. What are your thoughts?\"\n\n**Clinical Pearl:** Effective communication is vital in managing critically ill patients. SBAR provides a structured framework for conveying essential information and facilitating collaborative decision-making.",
      "highlight": []
    },
    "option_4": {
      "correct": true,
      "rationale": "**Correct:** Preparing to administer amiodarone is appropriate. The client is experiencing symptomatic ventricular arrhythmias (frequent PVCs, NSVT), which can lead to life-threatening ventricular tachycardia or fibrillation. Amiodarone is an antiarrhythmic medication used to stabilize cardiac rhythm. The PRN order indicates that it is available for this specific indication. The nurse should prepare the medication and be ready to administer it per the order, likely after confirming with the provider during the SBAR communication.\n\n**Pathophysiology:** Ventricular arrhythmias in the setting of cardiogenic shock are often caused by myocardial ischemia, electrolyte imbalances, and increased sympathetic tone. Amiodarone works by blocking potassium, sodium, and calcium channels, as well as alpha- and beta-adrenergic receptors, thereby prolonging the action potential duration and refractory period in cardiac tissue. This helps to suppress abnormal electrical activity and stabilize the heart rhythm.\n\n**Clinical Pearl:** Prompt treatment of ventricular arrhythmias is crucial in preventing cardiac arrest. Amiodarone is a commonly used antiarrhythmic agent, but it can have side effects, including hypotension and QT prolongation. Monitor the client closely during and after administration.",
      "highlight": []
    },
    "option_5": {
      "correct": false,
      "rationale": "**Incorrect:** Administering a fluid bolus is contraindicated. The client is in cardiogenic shock, characterized by pump failure and fluid overload. The elevated CVP (19 mmHg) and the presence of crackles in the lungs indicate pulmonary congestion. Administering a fluid bolus would increase preload on an already failing ventricle, worsening pulmonary edema and respiratory distress.\n\n**Pathophysiology:** In cardiogenic shock, the heart's inability to effectively pump blood leads to a backup of fluid in the pulmonary circulation. This increases pulmonary capillary hydrostatic pressure, causing fluid to leak into the interstitial space and alveoli, resulting in pulmonary edema. Increasing preload with a fluid bolus would exacerbate this process.\n\n**Clinical Pearl:** Assess for signs of fluid overload (crackles, edema, elevated CVP) before administering fluids to patients in cardiogenic shock. Fluid management should be carefully titrated to avoid worsening pulmonary congestion.",
      "highlight": []
    },
    "option_6": {
      "correct": false,
      "rationale": "**Incorrect:** While an ABG would provide valuable information about the client's oxygenation and acid-base status, it is not the priority action. The immediate life threat is the ventricular arrhythmia. The nurse's first actions must be to prevent further harm (withhold dobutamine), treat the existing electrical instability (notify provider, prepare amiodarone), and continuously monitor the client. An ABG can be obtained after these initial interventions.\n\n**Pathophysiology:** An ABG can reveal hypoxemia, hypercapnia, and metabolic acidosis, which are common in cardiogenic shock due to impaired tissue perfusion and oxygen delivery. However, addressing the underlying cardiac dysfunction and stabilizing the rhythm are more critical for immediate survival.\n\n**Clinical Pearl:** Prioritize interventions based on the ABCs (Airway, Breathing, Circulation). In this case, circulation (arrhythmia management) takes precedence over obtaining an ABG.",
      "highlight": []
    }
  },
  "references": [
    {
      "source": "American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.",
      "type": "Clinical Practice Guideline"
    },
    {
      "source": "Harding, M. M., Kwong, J., Roberts, D., Hagler, D., & Reinisch, C. (2023). Lewis's medical-surgical nursing: Assessment and management of clinical problems (12th ed.). Elsevier.",
      "type": "Textbook"
    }
  ],
  "sentinelStatus": "healed_v2026_v8"
}